Catalytic Antisense RNA (Ribozymes): Their Potential and Use as ANTI-HIV-1 Therapeutic Agents
Catalytic RNAs were first discovered as natural processes in several biological systems 1,2,3.Their discovery is one of the landmark accomplishments of modern science since it was the first demonstration that an informational molecule could also possess enzymatic activity, and hence changed our views on the possible origins of life. The discovery and characterization of the reactions carried out by RNA molecules has facilitated the development of an entirely distinct approach to antiviral therapy, the site specific, cleavage of viral RNAs mediated by catalytic, anti-sense ribozymes. We are using ribozymes as a novel antiviral strategy. In the following paragraphs, we weill describe the development of anti-sense ribozymes with the primary emphasis being their application as anti-HIV-1 therapeutic agents.
KeywordsCleavage Product Cleavage Reaction Hammerhead Ribozyme Catalytic Active Center Ribozyme Cleavage
Unable to display preview. Download preview PDF.
- 9.Chang, P.S., Cantin, E.M., Zaia, J.A., Ladne, P.A., Stephens, D.A., Sarver, N., Rossi, J.J., 1990, Ribozyme-mediated site-specific cleavage of the HIV-1 genome, Clinical Biotechnology 2:23.Google Scholar
- 14.Chatterjee, S., Wong, K.K., Rose, J.A., Johnson, P.R., 1991, Transduction of intracellular resistance to HIV production by an adeno-associated virus-based antisense vector. IN: Vaccine 91: Modern approaches to new vaccines including the prevention of AIDS. R.M. Channock, H.S. Ginberg, F. Brown and R.A. Lerner, eds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.Google Scholar